BioWorld

Jan. 22, 2002

View Archived Issues

House Committee Investigating ImClone’s Handling Of Erbitux

WASHINGTON A House committee on Friday said it will investigate New York-based ImClone Systems Inc.’s conduct in the development of its well-publicized drug for colorectal cancer. Read More

Pharmacopeia, Eos Scrap Merger Following Shareholder Opposition

Read More

Harvard Immunologist, California Firm Join In Hunt For Drugs To Check Human Asthma Onslaught

Read More

BIO’s Agenda Includes Quick Appointment Of FDA Leader

Read More

Holiday Notice

Read More

Other News To Note

Read More

Triangle Plans NDA For One Drug, Discontinues Another

Read More